뉴스&이벤트

<p>심유에 대한 새로운 뉴스와 이벤트를 알아보세요.</p>

심유 유동진 대표, ‘세계 임상시험의 날’ 보건복지부장관 표창 수상

Recognized for Outstanding Contributions to Clinical Trial Advancement and the Development of Indigenous Digital Clinical Trial Platforms in Korea   Dr. Dong Jin Yoo, Chief Executive Officer of SYMYOO Co., Ltd., has been awarded the Minister of Health and Welfare Commendation in recognition of his distinguished contributions to the advancement of clinical trials in Korea. … 심유 유동진 대표, ‘세계 임상시험의 날’ 보건복지부장관 표창 수상

Back to list

SYMYOO, ‘바이오 코리아 2026’ 참가… 독자 기술력 선보여

SYMYOO participated in ‘BIO KOREA 2026’ held at COEX for three days from April 28 to 30.   Marking its 21st anniversary, this year’s event was held under the theme “Innovation and Breakthrough, Towards a Better Future,” bringing together 586 companies from 55 countries for exhibitions, business partnering, and conferences.   Participating for the second … SYMYOO, ‘바이오 코리아 2026’ 참가… 독자 기술력 선보여

Back to list

심유, 숙명여자대학교 약학연구소(RIPS)와 전략적 공동 연구 협약 체결

The Research Institute of Pharmaceutical Sciences (RIPS) at Sookmyung Women’s University and Symyoo signed a Memorandum of Understanding (MoU) to strengthen research exchange and collaboration in the fields of basic and translational biomedical sciences.   This partnership is designed to foster collaboration in basic and translational medical sciences by combining the strengths and resources of … 심유, 숙명여자대학교 약학연구소(RIPS)와 전략적 공동 연구 협약 체결

Back to list

SYMYOO, ‘바이오 코리아 2025’서 뛰어난 임상연구 역량 선보인다

Symyoo, a leading full-service CRO with over 15 years of experience in clinical development, is participating in Bio Korea 2025. The company brings extensive expertise conducting over 250 clinical studies across more than 30 therapeutic areas, including oncology, rare diseases, neurology, and infectious diseases. Notably, two-thirds of Symyoo’s clinical trials have been registrational studies, highlighting … SYMYOO, ‘바이오 코리아 2025’서 뛰어난 임상연구 역량 선보인다

Back to list

심유, 차세대 임상시험 관리 시스템(CTMS) 1단계 공식 출시

SYMYOO, a full service CRO and digital healthcare technology company, has officially announced the launch of Phase 1 of its SYNeRA™️ Clinical Trial Management System (CTMS). This release marks a significant step toward streamlining clinical trial operations and ensuring high-quality data through an integrated digital solution, setting a new standard for clinical trial digitization. All-in-one, … 심유, 차세대 임상시험 관리 시스템(CTMS) 1단계 공식 출시

Back to list

심유, 대규모 RRCT ‘iTARGET-Elderly’ 연구 CRO로 선정

SYMYOO was selected as CRO for iTARGET-Elderly Study, a large-scale registry-based randomized controlled trial (RRCT) led by the Korean Diabetes Association (KDA). This study will compare and evaluate moderate-intensity statin therapy with an individualized LDL-C target-based therapy for the primary prevention effects of cardiovascular events in elderly patients with type 2 diabetes. The large-scale study … 심유, 대규모 RRCT ‘iTARGET-Elderly’ 연구 CRO로 선정

Back to list

심유, 디지털 임상연구의 혁신을 이끌다

SYMYOO is on track to become the most digitalized CRO by integrating advanced IT solutions into its home-grown EDC/ Clinical Trial Management System, in order to streamline patient recruitment and to boost trial efficiency. By combining proprietary digital systems with expert personnel, Symyoo has successfully launched the Man-Unmanned Teaming Clinical Trial (MUM-T CT) model, driving innovation … 심유, 디지털 임상연구의 혁신을 이끌다

Back to list

심유, 대한당뇨병학회(KDA) 대규모 RRCT ‘REMATCH’ 연구 지원

As a National Coordination Center, SYMYOO conducts REMATCH study, which is a very large-scale Registry-based Randomized Clinical Trial (RRCT) sponsored by the Korea Diabetes Association (KDA). This REMATCH study aims to define optimal type 2 diabetes management strategies that will improve cardiovascular and renal outcomes in type 2 diabetes mellitus patient population. Over 60 clinical … 심유, 대한당뇨병학회(KDA) 대규모 RRCT ‘REMATCH’ 연구 지원

Back to list

SYNeRA™ 플랫폼 DB 엔진 공식 출시

Smart Trial Research Center (STRC) at SYMYOO launches a new database engine, developed with multi-tier system architecture, meta-data driven and hierarchically structured database design. This SYNeRAᵀᴹ DB engine is optimized considering the systemic structural characteristics that easily reflect various system requirements from simple clinical studies to large-scale, multinational, and multi-center late-stage clinical trials, while enabling … SYNeRA™ 플랫폼 DB 엔진 공식 출시

Back to list

도들랩, IT 플랫폼 전문 기업으로 공식 출범

Symyoo established Dodlab, Inc., to create new innovations and values under the vision ‘Making the Better Place to Live with IT Technologies’.   Dodlab will pioneer new areas in the many industrial sectors, including the healthcare arena, and develop into a leading IT technology company with excellence in technology and expertise in order to help … 도들랩, IT 플랫폼 전문 기업으로 공식 출범

Back to list